Vanguard Group Inc Co Diagnostics, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,778,182 shares of CODX stock, worth $462,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,778,182
Previous 1,778,182
-0.0%
Holding current value
$462,327
Previous $1.33 Million
58.66%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
5.72MCall Options Held
35.6KPut Options Held
25.9K-
Private Advisory Group LLC Redmond, WA1.18MShares$307,2240.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny550KShares$143,0830.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$130,5260.0% of portfolio
-
Geode Capital Management, LLC Boston, MA342KShares$88,9640.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$70,9540.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $8.78M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...